Some of the constant characteristics of Mendelian autosomal dominant diseases are non-penetrance and variable expressivity. However, sickle cell anaemia (SSA) is probably unique among the autosomal recessive diseases in the variable expressivity of its natural history. It therefore seems likely that other factors extraneous to the sickle gene locus may play a part in full phenotypic expression of SSA. To find out the possible role of red cell antigens in the variable expressivity of SSA, ABO and Rhesus antigens have been determined in 200 electrophoreücally confirmed Hb SS patients and 250 sex- and age-matched Hb AA controls; the Hb SS group was subsequently divided into ‘mild’ and ‘severe’ sicklers and the results analysed. There were no statistically significant differences in the ABO and Rhesus blood group antigen distributions between the sicklers and Hb AA controls. There were also no correlations between the severity of the Hb SS disease and either the ABO or Rhesus group distributions. We conclude from these studies that ABO or Rhesus blood group antigens do not have significant moderating effect on the natural history of SSA.

Keywords:
Red cell antigens, Sickle cell anaemia
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.